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background: Although transcatheter aortic valve replacement (TAVR) was developed and has been extensively used for treatment of severe 
native tricuspid aortic stenosis (AS), it is now being applied in other anatomic subsets such as bicuspid AS. There is very limited information on the 
outcomes of these patients.
Methods: All patients with bicuspid AS who underwent TAVR in the STS/ACC Transcatheter Valve Therapy (TVT) Registry were analyzed and compared 
to patients undergoing TAVR for tricuspid valve AS.
results: Among 7,806 patients in the TVT Registry in whom valve anatomy was documented, 144 (1.84%) had a bicuspid valve. Compared with 
patients with tricuspid AS, bicuspid AS patients were younger (77.5 vs. 84.88 years, p<0.001), less likely to have underlying conduction system 
disease (21.53% vs. 29.26%, p=0.0707), tended to have a lower Euro Score II (5.71 vs. 6.70, p=0.07) and had lower STS score (6.10 vs. 6.96 
p=0.002). There was no baseline aortic regurgitation (AR) in 29.17% of bicuspid patients vs. 19.21% of tricuspid patients respectively; moderate 
AR was similar in frequency (16.67% vs. 16.94%). Aortic valve area was similar (0.70 cm2 vs. 0.64 cm2, p=0.13), although the bicuspid median 
aortic annulus was larger 23 vs. 22 mm (p=0.001). Post-implant calculated aortic valve area was 1.94 cm2 vs. 1.90 cm2 respectively (p=0.72). 
Site-reported AR severity was trace/trivial in 19.35% vs. 21.89% and moderate/severe in 4.84% vs. 6.53%. Mild AR was seen in 21% and 24% 
respectively. In-hospital mortality was similar (4.2% vs. 5.5%, p=0.5159). In-hospital death from any cause or stroke occurred in 6.2% vs. 7.1% 
(p=0.75).
conclusion: Among patients undergoing TAVR in U.S. clinical practice, those with bicuspid valves had somewhat lower pre-procedural risk 
compared to those with tricuspid aortic valves. Post-procedure valve measurements and major in-hospital clinical outcomes were similar between 
the groups. Bicuspid valve morphology does not appear to compromise TAVR results in clinical practice, and may support a TAVR procedural 
indication for these patients similar to patients with tricuspid valves.
